Stockman Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Stockman Wealth Management's GILD Position: Q2 2020 in Review
Stockman Wealth Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 9,528 shares — an estimated $712K sold.
Stockman Wealth Management first reported a position in GILD in Q2 2016 and held it in 16 quarters. The position peaked at $4.25M in Q4 2019. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.
- Stockman Wealth Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
- Stockman Wealth Management sold 9,528 Gilead Sciences shares in Q2 2020, an estimated $712K.
- Stockman Wealth Management first reported a position in Gilead Sciences in Q2 2016 and held it in 16 quarters.
- Stockman Wealth Management's Gilead Sciences position peaked at $4.25M in Q4 2019.
- 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.
Based on Stockman Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.